Non-resectable Pancreatic Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-01-29
Clinical Trial Update: Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer [Phase 2]
A Phase 2 trial compares gemcitabine to a reduced-dose combination chemotherapy in fragile patients with non-resectable pancreatic cancer; t…